荷尔蒙补充疗法(HRT)的全球市场:规模，占有率，成长分析-疗法各类型，各适应症，各给药途径-产业预测(2023年～2030年)

Global Hormone Replacement Therapy Market Size, Share, Growth Analysis, By Therapy Type, By Indication, By Route of Administration - Industry Forecast 2023-2030

出版日期: 2023年04月22日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球荷尔蒙补充疗法(HRT)的市场规模，2021年为249亿7,000万美金，从2022年的268亿7,000万美元，预计到2030年成为492亿5,000万美元。从2023年到2030年的预测期间内的年复合成长率成为7.83％。胆固醇值的上升，含血栓、胀感、肿等问题的副作用的可能性，抑制市场成长。

本报告提供全球荷尔蒙补充疗法(HRT)市场的相关调查，市场概要，市场分析，企业简介等全面性资讯。

市场概要
市场规模
市场动态
促进因素
机会
阻碍因素
课题
主要的市场洞察
技术分析
价格分析
供应链分析
价值链分析
市场生态系统
知识产权分析
贸易分析
Start-Ups分析
原料分析
革新矩阵
开发中产品的分析
宏观经济指标
主要投资分析
主要的成功因素
竞争的程度
市场动态与展望
市场动态
促进因素
机会
阻碍因素
课题
法规情形
波特分析
竞争企业间的敌对关係
替代产品的威胁
买方议价能力
新加入业者的威胁
供给企业谈判力
未来的混乱相关Skyquest的特别的洞察
政治影响
经济影响
社会影响
技术影响
环境影响
法律影响
全球荷尔蒙补充疗法(HRT)市场:各疗法类型
市场概要
雌激素、并用补充疗法
甲状腺荷尔蒙补充疗法
成长荷尔蒙补充疗法
睪固酮荷尔蒙补充疗法
全球荷尔蒙补充疗法(HRT)市场:各适应症
市场概要
闭经
甲状腺机能低下症
男性的性腺功能降低症
生长激素缺乏症
全球荷尔蒙补充疗法(HRT)市场:各给药途径
市场概要
口服
经皮
非口服
全球荷尔蒙补充疗法(HRT)市场规模:各地区
市场概要
北美
美国
加拿大
欧洲
德国
西班牙
法国
英国
其他的欧洲
亚太地区
中国
印度
日本
韩国
其他的亚太地区
南美
巴西
其他的南美
中东、非洲
GCC各国
南非
其他的中东、非洲
竞争情形
主要5家公司的比较
主要企业的市场上的定位(2021年)
主要的市场参与企业采用的策略
主要成功策略
各开发
各企业
各年度
市场上最近的活动
主要企业的市场占有率(%)(2021年)
主要的企业简介
Eli Lilly and Company(美国)
Bayer AG(德国)
Pfizer Inc.(美国)
Viatris, Inc.(美国)
Novo Nordisk A/S
Novartis International AG
Merck & Co. Inc.
Mylan N.V.
TherapeuticsMD Inc.
Abbott Laboratories
Allergan plc
Teva Pharmaceutical Industries Ltd.
Amgen Inc.
AbbVie Inc.
Ferring Pharmaceuticals
GlaxoSmithKline plc
Johnson & Johnson
Ipsen S.A.
Sanofi S.A.

简介目录

Product Code: SQMIG35F2010

Hormone Replacement Therapy (HRT) Market size was valued at USD 24.97 billion in 2021 and is poised to grow from USD 26.87 billion in 2022 to USD 49.25 billion by 2030, growing at a CAGR of 7.83% in the forecast period (2023-2030).

For many years, women with menopause-related disorders have been successfully treated with hormone replacement therapy. As a result, the risk of osteoporosis has decreased, as have other menopause symptoms including hot flashes. Due to the development in additional hormone-related ailments that are targeted at different age groups and affect both women and men, these therapies are also causing the market to grow. Therefore, it is anticipated that over the projection period, conditions like thyroid disorders, growth deficits, and others would speed up market expansion on a global scale.

The hormone replacement therapy (HRT) industry is growing as a result of factors like the availability of long-acting hGH products and the rising prevalence of target disorders. According to the American Thyroid Association, thyroid disease will affect 12% of Americans at some point in their lives. Furthermore, it mentioned that roughly 20 million Americans have thyroid illness. According to numerous studies, people on HRT presumably had a low risk of COVID-19 infection and mortality.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (HRT) Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

Global hormone replacement therapy (HRT) market is segmented based on therapy type, indication and region. Based on therapy type, the market is segmented into estrogen & combinations replacement therapy, thyroid hormone replacement therapy, growth hormone replacement therapy, testosterone hormone replacement therapy segments. On the basis of indication, the market can be bifurcated into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency segments. Based on the route of administration, the market is segregated into oral, transdermal and parenteral route segments. The regional insights of the market are into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa.

Driver

People with growth hormone deficiency, menopausal symptoms in women, and hypogonadism in the elderly are among the many people who require the therapy. The drug is available in a variety of forms, such as skin and buccal patches, injections, tablets, and others. Producers are focusing on developing innovative medicine delivery systems, such as transdermal oestrogen patches and vaginal oestrogen pills, as a result of the rising use of these products around the world. In line with the safety worries, they are focusing more on the introduction of low dose oestrogen therapy than high dose oestrogen therapy. The key competitors in the global market have also embraced the launch of gel-based formulations for items like oestrogen patches.

Restraint

Market expansion is being negatively impacted by some issues. Patches, gel, pills, and injections are just a few of the several therapeutic formulations available. However, these medications' possible adverse effects, which include an increase in cholesterol levels, blood clots, bloating, swelling, and other issues, may limit market growth.

Additionally, it is projected that the adverse effects of testosterone replacement therapy, such as benign prostatic hyperplasia, obstructive sleep apnea, and prostate cancer, may restrain market growth. Due to the rise in cardiovascular disorders among patients undergoing testosterone replacement therapy, the US FDA has also expressed concern regarding the approved indication and the increasing incidences of cardiovascular risks associated with the products used in testosterone replacement therapy.

Market Trends

The growth in unmet demand for hormone replacement therapy in emerging countries and the greater awareness of the treatment of hormone issues are driving pharmaceutical companies to continuously bring new cutting-edge pharmaceuticals to the global market. In addition, the prevalence of menopause and diseases linked to hormone deficiency in developed countries has led manufacturers to develop new products such combination treatment solutions in place of the long-acting parenteral drugs that were formerly used daily.